echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Science Advances: Loss of circadian rhythm regulation leads to increased glucose production during lung cancer

    Science Advances: Loss of circadian rhythm regulation leads to increased glucose production during lung cancer

    • Last Update: 2021-07-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The biological clock is our internal biological pacemaker, which can maintain the physiological homeostasis of all tissues in the body
    .


    The circadian clock is responsible for controlling physiological, endocrine and metabolic processes,such as glucose production andconsumption, lipid metabolism, amino acids, and nucleotides, which is a rhythmic cycle through the day and night


    The biological clock is our internal biological pacemaker, which can maintain the physiological homeostasis of all tissues in the body


    The mechanism of how the circadian clock adapts to environmental disturbances has been characterized in the diet and nutrition challenge paradigm , but little is known about how the circadian clock participates in metabolic adaptation to disease states


    During the progression of lung cancer and the corresponding development of cachexia, the control of the circadian rhythm of glucose production is disrupted, leading to increased liver glucose levels


    A new study from the University of California, Irvine, published in the journal Science Advances , reveals how the circadian regulation of glucose production in the liver is lost during lung cancer progression, and how the resulting increase in glucose production promotes cancer cell growth .

    A University of California, Irvine, in the published in " Advances in science and scientific progress in the journal" The new study revealed a circadian rhythm during the progression of lung cancer in the liver glucose production to adjust how the loss, and the resulting increase in glucose production how to promote cancer Grow
    .


    How the circadian regulation of glucose production in the liver is lost during lung cancer progression, and how the resulting increase in glucose production promotes cancer cell growth


     

    The study showed that REV-ERBα, a key circadian protein, controls glucose production in the liver
    .


    Studies have found that elevated serum glucagon levels stimulate the production of cyclic adenosine monophosphate and activate hepatic protein kinase A (PKA) signaling in TB mice


    The study showed that REV-ERBα, a key circadian protein, controls glucose production in the liver


    During lung cancer progression, especially in the case of cachexia, this circadian rhythm regulation is lost, leading to increased glucose production by the liver," said senior author Dr.


    This study uses the biological clock as the central regulator of glucose production during lung cancer progression and provides important insights for the development of new therapies that target REV-ERBα to inhibit the growth of cancer cells .

    This research uses the biological clock as the central regulator of glucose production during lung cancer progression, and provides important insights for the development of new therapies that target REV-ERBα to inhibit the growth of cancer cells .



    "We are the new track produced by glucose glucose to continue to study the metabolic fate of glucose in the process of progression of lung cancer increased production consequences, in order to determine whether the fuel source may promote lung cancer cell cells increased metabolic demands," medical medical Boshi Amandine Verlande said


    References : Glucagon regulates the stability of REV-ERBα to modulate hepatic glucose production in a model of lung cancer–associated cachexia

    DOI: 10.


    1126/sciadv.
    abf3885

    DOI: 10.
    1126/sciadv.
    abf3885 DOI: 10.
    1126/sciadv.


     Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.